Important Facts, Concepts, and Data to know about CVD, Cognitive Impairment, and Corruption in AD Research
As many providers can attest, Alzheimer’s Dementia (AD) is a complex brain disease that slowly destroys a person’s memory and thinking abilities until sufferers become so debilitated that they cannot carry out the simplest of tasks (1). Over six million Americans over the age of 65 suffer from dementia (1). Even grimmer, as the condition progresses, it can become fatal within as little as 3-10 years (1). Few providers would disagree with these statements. Where the tables turn is the consensus on the causes of dementia, who will get it, and whether or not dementia is a destined part of aging. Dementia is debilitating, life-altering, and ultimately, life-ending. The question is, does it have to be? Can dementia be prevented or even reversed?
Every year I struggle with the decision as to what topic would be the most appropriate for the next APIM Annual Summit. Three years ago, at Hormones & Beyond Symposium 2019, we reviewed diabetes, fasting, treatment options, and pathophysiology. Two years ago, we covered How Estrogenics are making you Fat, Sick, and Infertile. Last year, we reviewed cancer, hormones, cardiovascular disease, and prostate cancer. So, now what? Fortunately, the FDA has recently approved the first and only treatment for Alzheimer’s Disease. This was extremely political and controversial. Also recently, I attended a lecture by Dale Bredesen from U.C.L. A., a world’s expert on dementia and Alzheimer’s Disease. As a result of the foregoing, the topic for this year’s symposium was easy.